Embolic Agents: Sclerotherapy

Christina Lim; Sean Lee; Abheek Ghosh; Brian Funaki

doi:10.1055/s-0043-1778656

Seminars in Interventional Radiology, Inhaltsverzeichnis

Semin intervent Radiol 2024; 41(01): 079-083
DOI: 10.1055/s-0043-1778656

Back to Basics

Embolic Agents: Sclerotherapy

Christina Lim

¹Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, Creighton University School of Medicine, Baltimore, Maryland

,

Sean Lee

²Touro College of Osteopathic Medicine, New York City, New York

,

Abheek Ghosh

³Division of Vascular and Interventional Radiology, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine, Baltimore, Maryland

,

Brian Funaki

⁴Division of Vascular and Interventional Radiology, University of Chicago Medicine, Chicago, Illinois

References
1 Myers K. A history of injection treatments - II sclerotherapy. Phlebology 2019; 34 (05) 303-310
2 Borecka-Sobczak J. Sclerotherapy - from historical research to the modern and efficient method of phlebological treatment. Phlebological Rev 2021; 29 (01) 1-6
3 Albanese G, Kondo KL. Pharmacology of sclerotherapy. Semin Intervent Radiol 2010; 27 (04) 391-399
4 Mancini S, Lassueur F, Mariani F. Sclerosis of the great saphenous vein: an experimental study in humans of the sclerosing effect of an iodo-iodide solution and polidodecane (histology and electron microscopy). Phlébologie (Paris) 1991; 44 (02) 461-468
5 Urbanek TR, Piotr M, Jolanta A. et al. Sclerotherapy contraindications, sequelaes, and complications - informing patients properly and objectively is required. Phlebological Rev 2021; 29: 19-25
6 Bergan JJ, Bunke-Paquette N. eds. The Vein Book. New York, NY: Oxford University Press; 2014: 149-166
7 Worthington-Kirsch RL. Injection sclerotherapy. Semin Intervent Radiol 2005; 22 (03) 209-217
8 Duffy DMM. Sclerosants: a comparative review. Dermatol Surg 2010; 36 (2, Suppl 2): 1010-1025
9 Schwartz L, Maxwell H. Sclerotherapy for lower limb telangiectasias. Cochrane Database Syst Rev 2011; 2011 (12) CD008826
10 Leach BCMG, Goldman MP. Comparative trial between sodium tetradecyl sulfate and glycerin in the treatment of telangiectatic leg veins. Dermatol Surg 2003; 29 (06) 612-614 , discussion 615
11 Do YS, Yakes WF, Shin SW. et al. Ethanol embolization of arteriovenous malformations: interim results. Radiology 2005; 235 (02) 674-682
12 Dubois J. Percutaneous sclerotherapy: recipe for perfect cooking. Pediatr Radiol 2011; 41 (01) 107-109
13 Sood A, Kotamarti VS, Therattil PJ, Lee ES. Sclerotherapy for the management of seromas: a systematic review. Eplasty 2017; 17: e25
14 Nevesny F, Chevallier O, Falvo N. et al. Bleomycin for percutaneous sclerotherapy of venous and lymphatic malformations: a retrospective study of safety, efficacy and mid-term outcomes in 26 patients. J Clin Med 2021; 10 (06) 1302
15 Ghosh A, Xiao N, Gordon AC, Funaki B, Lewandowski RJ. Embolic agents: vascular plugs. Semin Intervent Radiol 2022; 39 (05) 526-532
16 Lee S, Ghosh A, Xiao N. et al. Embolic agents: particles. Semin Intervent Radiol 2023; 40 (03) 315-322
17 Goldman MW, Guex J-J, Weiss RA. eds. Clinical methods for sclerotherapy of varicose veins. In: Sclerotherapy: Treatment of Varicose and Telangiectatic Leg Veins. Elsevier; 2017: 262-346
18 Chung JB, Nam DK, Han KH. et al. Endoscopic injection sclerotherapy in patients with bleeding esophageal varices: a retrospective analysis. Korean J Intern Med (Korean Assoc Intern Med) 1990; 5 (01) 5-14
19 Farooq FT, Wong RCK. Injection sclerotherapy for the management of esophageal and gastric varices. Tech Gastrointest Endosc 2005; 7 (01) 8-17
20 Sabri SS, Saad WE. Balloon-occluded retrograde transvenous obliteration (BRTO): technique and intraprocedural imaging. Semin Intervent Radiol 2011; 28 (03) 303-313
21 Li N, Li J, Huang M, Zhang X. Efficacy and safety of polidocanol in the treatment of varicose veins of lower extremities: a protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021; 100 (08) e24500
22 Orlando JL, Caldas JG, Campos HG, Nishinari K, Krutman M, Wolosker N. Ethanol sclerotherapy of head and neck venous malformations. Einstein (Sao Paulo) 2014; 12 (02) 181-186
23 Clemens RK, Sebastian T, Kerr C, Alomari AI. Clinical uses and short-term safety profile of ethiodized poppy seed oil contrast agent in the diagnosis and treatment of vascular anomalies and tumors. Diagnostics (Basel) 2021; 11 (10) 1776
24 Munavalli GS, Weiss RA. Complications of sclerotherapy. Semin Cutan Med Surg 2007; 26 (01) 22-28